MicroRNA as Therapeutics for Age-Related Macular Degeneration
- 3 May 2018
- book chapter
- Published by Springer Nature
- Vol. 1074, 37-43
Abstract
MicroRNA (miRNA) are a class of endogenously expressed small non-coding RNA molecules that function by repressing or silencing post-transcriptional gene expression. While miRNAs were only identified in humans as recently as the turn of this century, some miRNA-based agents are already in Phase 2 clinical trials (Christopher et al. 2016 ). This rapid progress from initial discovery to drug development reflects the effectiveness of miRNAs as therapeutic targets. Further, their use as therapeutic agents in the treatment of diseases such as Alzheimer’s disease (Wang et al. 2014 ) supports their use in other neurodegenerative diseases, such as Age-Related Macular Degeneration (AMD). However, despite ∼300 miRNAs reportedly expressed in the human retina (Xu 2009 ), relatively little research has been conducted into the therapeutic potential of miRNAs for the treatment of AMD. This review will investigate the use of miRNAs as therapeutic and diagnostic molecules for AMD.Keywords
This publication has 29 references indexed in Scilit:
- An Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease PathologyMolecular Diagnosis & Therapy, 2016
- microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular DegenerationPLOS ONE, 2016
- MicroRNA therapeutics: Discovering novel targets and developing specific therapyPerspectives in Clinical Research, 2016
- Regulation of microRNA biogenesisNature Reviews Molecular Cell Biology, 2014
- Roles and Mechanism of miR-199a and miR-125b in Tumor AngiogenesisPLOS ONE, 2013
- Circulating MicroRNAsCirculation Research, 2012
- MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8Aging, 2009
- Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signalsProceedings of the National Academy of Sciences, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease PathwaysJournal of Alzheimer’s Disease, 2008